Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q2 2026 13F · SEC CIK 1719307

Beryl Capital Management LLC

Hedge fundFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$110.7M
Reported positions
7
Holdings vs S&P 500, 3 yrs
—
Assets under management
$1.0B

Beryl Capital Management LLC is a hedge fund that reported 7 positions worth $110.7M in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Janus Henderson Group PLC (JHG, 66.4%), Esperion Therapeutics Inc Ne (ESPR, 12.7%), Apogee Therapeutics Inc (APGE, 7.0%).

Beryl Capital Management LLC holdings all 7 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Beryl Capital Management LLC 13F holdings
Stock% of 13F valueShare changeReported value
JHGJanus Henderson Group PLC66.4%—$73.5M
ESPREsperion Therapeutics Inc Ne12.7%—$14.0M
APGEApogee Therapeutics Inc7.0%—$7.8M
SILASila Realty Trust Inc5.5%—$6.1M
AVNSAvanos Med Inc3.5%—$3.9M
TMHCTaylor Morrison Home Corp3.2%—$3.6M
SNXTD SYNNEX Corp1.7%—$1.8M

What Beryl Capital Management LLC bought and sold in Q2 2026, against Q1 2026.

Added to

No position grew by more than 5%.

Reduced

No position shrank by more than 5%.

Share counts compared with the Q1 2026 13F; a split also changes share counts.

How the holdings did against the S&P 500.

1 year
+35.7% /yr
S&P 500 +22.0%
3 years
—
5 years
—

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q2 2026$110.7M7
Q1 2026$108.6M8
Q4 2025$986.3M15
Q3 2025$52.0M6
Q2 2025$664.0M28
Q1 2025$267.7M13
Q4 2024$442.6M31
Q3 2024$462.9M29
Q2 2024$332.6M24
Q1 2024$81.0M16
Q4 2023$182.1M20
Q3 2023$786.6M30

Questions about Beryl Capital Management LLC's portfolio

What stocks does Beryl Capital Management LLC own?

Beryl Capital Management LLC's latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 7 positions worth $110.7M. The largest are Janus Henderson Group PLC (JHG) at 66.4%, Esperion Therapeutics Inc Ne (ESPR) at 12.7%, Apogee Therapeutics Inc (APGE) at 7.0%, Sila Realty Trust Inc (SILA) at 5.5% and Avanos Med Inc (AVNS) at 3.5%.

What did Beryl Capital Management LLC buy last quarter?

In Q2 2026, Beryl Capital Management LLC added a new position in Janus Henderson Group PLC (JHG), a new position in Esperion Therapeutics Inc Ne (ESPR), a new position in Apogee Therapeutics Inc (APGE), a new position in Sila Realty Trust Inc (SILA) and a new position in Avanos Med Inc (AVNS), compared with its Q1 2026 filing.

What did Beryl Capital Management LLC sell last quarter?

In Q2 2026, Beryl Capital Management LLC sold all of Masimo Corp (MASI), sold all of Terns Pharmaceuticals Inc (TERN), sold all of Great Lakes Dredge & Dock Co (GLDD), sold all of Day One Biopharmaceuticals Inc (DAWN) and sold all of Sunopta Inc (STKL), compared with its Q1 2026 filing.

When is Beryl Capital Management LLC's next 13F filing due?

13F filings are due 45 days after each quarter ends. Beryl Capital Management LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Beryl Capital Management LLC manage?

Beryl Capital Management LLC reported $1.0B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $110.7M.